1
|
Hewitt KJ, Löffler CML, Muti HS, Berghoff AS, Eisenlöffel C, van Treeck M, Carrero ZI, El Nahhas OSM, Veldhuizen GP, Weil S, Saldanha OL, Bejan L, Millner TO, Brandner S, Brückmann S, Kather JN. Direct image to subtype prediction for brain tumors using deep learning. Neurooncol Adv 2023; 5:vdad139. [PMID: 38106649 PMCID: PMC10724115 DOI: 10.1093/noajnl/vdad139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2023] Open
Abstract
Background Deep Learning (DL) can predict molecular alterations of solid tumors directly from routine histopathology slides. Since the 2021 update of the World Health Organization (WHO) diagnostic criteria, the classification of brain tumors integrates both histopathological and molecular information. We hypothesize that DL can predict molecular alterations as well as WHO subtyping of brain tumors from hematoxylin and eosin-stained histopathology slides. Methods We used weakly supervised DL and applied it to three large cohorts of brain tumor samples, comprising N = 2845 patients. Results We found that the key molecular alterations for subtyping, IDH and ATRX, as well as 1p19q codeletion, were predictable from histology with an area under the receiver operating characteristic curve (AUROC) of 0.95, 0.90, and 0.80 in the training cohort, respectively. These findings were upheld in external validation cohorts with AUROCs of 0.90, 0.79, and 0.87 for prediction of IDH, ATRX, and 1p19q codeletion, respectively. Conclusions In the future, such DL-based implementations could ease diagnostic workflows, particularly for situations in which advanced molecular testing is not readily available.
Collapse
Affiliation(s)
- Katherine J Hewitt
- Department of Medicine III, University Hospital RWTH Aachen, Aachen, North Rhine-Westphalia, Germany
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
| | - Chiara M L Löffler
- Department of Medicine III, University Hospital RWTH Aachen, Aachen, North Rhine-Westphalia, Germany
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
- Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Saxony, Germany
| | - Hannah Sophie Muti
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
- Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus Dresden, Dresden, Saxony, Germany
| | - Anna Sophie Berghoff
- Department of Medicine 1, Division of Oncology, Medical University of Vienna, Vienna, Vienna, Austria
| | - Christian Eisenlöffel
- Department of Pathology, St. Georg Teaching Hospital, University of Leipzig, Leipzig, Saxony, Germany
| | - Marko van Treeck
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
| | - Zunamys I Carrero
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
| | - Omar S M El Nahhas
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
| | - Gregory P Veldhuizen
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
| | - Sophie Weil
- Neurology Clinic, Department of Neurology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Baden- Württemberg, Germany
- Clinical Cooperation Unit Neuro-oncology, Department of Neurology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Baden- Württemberg, Germany
| | - Oliver Lester Saldanha
- Department of Medicine III, University Hospital RWTH Aachen, Aachen, North Rhine-Westphalia, Germany
| | - Laura Bejan
- School of Medicine, Faculty of Medicine and Dentistry, University College London, London, Greater London, UK
| | - Thomas O Millner
- Division of Neuropathology, Queen Square Institute of Neurology, University College London, London, Greater London, UK
- Blizard Institute, Faculty of Medicine and Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, Greater London, UK
| | - Sebastian Brandner
- Division of Neuropathology, Queen Square Institute of Neurology, University College London, London, Greater London, UK
| | - Sascha Brückmann
- Institut für Pathologie, University Hospital Carl Gustav Carus, Dresden, Saxony, Germany
| | - Jakob Nikolas Kather
- Department of Medicine III, University Hospital RWTH Aachen, Aachen, North Rhine-Westphalia, Germany
- Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Saxony, Germany
- Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Saxony, Germany
- Pathology & Data Analytics, Faculty of Medicine and Health, Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds, West Yorkshire, UK
- Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Baden- Württemberg, Germany
| |
Collapse
|